CODX Ebit from 2010 to 2024
| CODX Stock | USD 0.94 0.01 1.08% |
EBIT | First Reported 2015-12-31 | Previous Quarter -7.7 M | Current Value -10.2 M | Quarterly Volatility 7.6 M |
Check Co Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Co Diagnostics' main balance sheet or income statement drivers, such as Interest Expense of 18 M, Selling General Administrative of 15 M or Total Revenue of 6.5 M, as well as many indicators such as Price To Sales Ratio of 5.44, Dividend Yield of 0.0 or PTB Ratio of 0.43. CODX financial statements analysis is a perfect complement when working with Co Diagnostics Valuation or Volatility modules.
CODX | Ebit |
Latest Co Diagnostics' Ebit Growth Pattern
Below is the plot of the Ebit of Co Diagnostics over the last few years. It is Co Diagnostics' EBIT historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Co Diagnostics' overall financial position and show how it may be relating to other accounts over time.
| Ebit | 10 Years Trend |
|
Ebit |
| Timeline |
CODX Ebit Regression Statistics
| Arithmetic Mean | (2,171,683) | |
| Coefficient Of Variation | (1,066) | |
| Mean Deviation | 13,130,124 | |
| Median | (1,687,966) | |
| Standard Deviation | 23,145,343 | |
| Sample Variance | 535.7T | |
| Range | 88.8M | |
| R-Value | (0.19) | |
| Mean Square Error | 556.1T | |
| R-Squared | 0.04 | |
| Significance | 0.50 | |
| Slope | (983,724) | |
| Total Sum of Squares | 7499.9T |
CODX Ebit History
Other Fundumenentals of Co Diagnostics
About Co Diagnostics Financial Statements
Co Diagnostics investors use historical fundamental indicators, such as Co Diagnostics' Ebit, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Co Diagnostics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| EBIT | -42.7 M | -40.6 M | |
| EBITDA | -41.5 M | -39.4 M | |
| Ebt Per Ebit | 0.89 | 0.90 | |
| Ebit Per Revenue | (6.27) | (6.58) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for CODX Stock Analysis
When running Co Diagnostics' price analysis, check to measure Co Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Co Diagnostics is operating at the current time. Most of Co Diagnostics' value examination focuses on studying past and present price action to predict the probability of Co Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Co Diagnostics' price. Additionally, you may evaluate how the addition of Co Diagnostics to your portfolios can decrease your overall portfolio volatility.